PANK-003 Cell Injection Combined with Standard Adjuvant Chemotherapy After Surgery in Patients with Solid Tumors

Clinical trial NCT06897228 · RECRUITING

Trial details

NCT number: NCT06897228
Sponsor: Shenzhen Celconta Life Science Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors, Adult

Start date: 2024-02-18
Primary completion: 2027-01-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.